Status:
COMPLETED
Helminth Infection During Pregnancy on Vitamin D Regulation: HELMVIT Study
Lead Sponsor:
Centre de Recherche Médicale de Lambaréné
Collaborating Sponsors:
Technical University of Munich
University Hospital Tuebingen
Conditions:
Vitamin D Deficiency
Immunosuppression
Eligibility:
FEMALE
Brief Summary
Purpose: To examine whether helminth infection during pregnancy alters Vitamin-D-metabolism and reactivity of the child's immune system Hypothesis: Helminth infection during pregnancy is associated w...
Detailed Description
Objectives The primary objective of the proposed research project is to study the impact of helminth infection in general and particularly of infection with S. haematobium during pregnancy on Vitamin ...
Eligibility Criteria
Inclusion
- Pregnant women attending antenatal care from Lambaréné and Fougamou areas
- Pregnant women who have given written informed consent to the study for herself and for her unborn child and live infant.
Exclusion
- Known of chronic infections and diseases(e.g. diabetes, HIV, Hepatitis B and C, anemia).
Key Trial Info
Start Date :
January 28 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04324853
Start Date
January 28 2019
End Date
December 31 2022
Last Update
June 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Josiane Y Honkpehedji
Lambaréné, Moyen-Ogooué Province, Gabon, BP 242